Ownership history in Opaleye Management Inc. · 10 quarters on record
This page tracks every 13F SEC filing in which Opaleye Management Inc. reported a position in SUTRO BIOPHARMA INC (STRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 190,671 | -110,820 | -36.8% | 0.29% | $2.2M | $11.57 |
| 2023 Q4 | REDUCED | 301,491 | -5,509 | -1.8% | 0.34% | $1.3M | $42.90 |
| 2023 Q2 | ADDED | 307,000 | +217,020 | +241.2% | 0.34% | $1.4M | $46.50 |
| 2022 Q1 | REDUCED | 89,980 | -590,020 | -86.8% | 0.23% | $740K | $82.20 |
| 2021 Q4 | ADDED | 680,000 | +142,200 | +26.4% | 2.15% | $10.1M | $148.80 |
| 2021 Q3 | ADDED | 537,800 | +40,900 | +8.2% | 1.90% | $10.2M | $188.90 |
| 2021 Q2 | ADDED | 496,900 | +154,950 | +45.3% | 1.53% | $9.2M | $185.90 |
| 2021 Q1 | ADDED | 341,950 | +19,750 | +6.1% | 1.14% | $7.8M | $227.60 |
| 2020 Q4 | ADDED | 322,200 | +176,200 | +120.7% | 0.91% | $7.0M | $217.10 |
| 2020 Q3 | INITIATED | 146,000 | — | — | 0.29% | $1.5M | $100.50 |
As of 2025 Q4 — sorted by position size